An anthracycline antibiotic that has formula C27H29NO11.
Chemical ID:
MESH:D004317
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
CYP2J2 protein inhibits the reaction [Doxorubicin results in increased activity of CAT protein]; FNDC5 protein inhibits the reaction [Doxorubicin results in decreased expression of and results in decreased activity of CAT protein]; Hesperidin inhibits the reaction [Doxorubicin results in increased activity of CAT protein]; indole-3-carbinol inhibits the reaction [Doxorubicin results in decreased activity of CAT protein]; Luteolin inhibits the reaction [Doxorubicin results in increased activity of CAT protein]; Meloxicam inhibits the reaction [Doxorubicin results in decreased activity of CAT protein]; MT1 affects the reaction [Doxorubicin results in increased expression of CAT protein]; MT2 affects the reaction [Doxorubicin results in increased expression of CAT protein]; naringin inhibits the reaction [Doxorubicin results in decreased expression of CAT protein]; Plant Extracts inhibits the reaction [Doxorubicin results in increased activity of CAT protein]; Silymarin inhibits the reaction [Doxorubicin results in decreased expression of CAT protein]; SIRT6 gene mutant form promotes the reaction [Doxorubicin results in increased expression of CAT mRNA]; SIRT6 gene mutant form promotes the reaction [Doxorubicin results in increased expression of CAT protein]
caffeic acid phenethyl ester inhibits the reaction [Doxorubicin results in decreased activity of CAT protein]; caffeic acid phenethyl ester promotes the reaction [Doxorubicin results in increased activity of CAT protein]; Carnitine inhibits the reaction [Doxorubicin results in decreased activity of CAT protein]; caryophyllene inhibits the reaction [Doxorubicin results in decreased activity of CAT protein]; Catechin inhibits the reaction [Doxorubicin results in decreased activity of CAT protein]; Chitosan analog inhibits the reaction [Doxorubicin results in decreased activity of CAT protein]; corilagin inhibits the reaction [Doxorubicin results in decreased activity of CAT protein]; Curcumin inhibits the reaction [Doxorubicin results in decreased activity of CAT protein]; Doxorubicin affects the expression of and affects the activity of CAT protein; Doxorubicin results in decreased expression of and results in decreased activity of CAT protein; epigallocatechin gallate affects the reaction [Doxorubicin affects the expression of and affects the activity of CAT protein]; FNDC5 protein modified form inhibits the reaction [Doxorubicin results in decreased expression of and results in decreased activity of CAT protein]; FNDC5 protein modified form inhibits the reaction [Doxorubicin results in decreased expression of CAT mRNA]; Grape Seed Proanthocyanidins inhibits the reaction [Doxorubicin results in decreased expression of CAT protein]; iodopravadoline inhibits the reaction [caryophyllene inhibits the reaction [Doxorubicin results in decreased activity of CAT protein]]; kaempferol inhibits the reaction [Doxorubicin results in decreased activity of CAT protein]; Lycopene affects the reaction [Doxorubicin affects the activity of CAT protein]; Melatonin inhibits the reaction [Doxorubicin results in increased activity of CAT protein]; Metformin inhibits the reaction [Doxorubicin results in decreased expression of CAT mRNA]; morin inhibits the reaction [Doxorubicin results in decreased activity of CAT protein]; NFE2L2 protein promotes the reaction [FNDC5 protein modified form inhibits the reaction [Doxorubicin results in decreased expression of CAT mRNA]]; Nicorandil inhibits the reaction [Doxorubicin results in decreased expression of CAT protein]; pimagedine inhibits the reaction [Doxorubicin results in decreased expression of CAT protein]; Plant Extracts inhibits the reaction [Doxorubicin results in decreased activity of CAT protein]; Plant Preparations inhibits the reaction [Doxorubicin results in decreased expression of CAT protein]; plumbagin inhibits the reaction [Doxorubicin results in decreased expression of CAT protein]; Poly(ADP-ribose) Polymerase Inhibitors inhibits the reaction [Doxorubicin results in decreased activity of CAT protein]; Proanthocyanidins inhibits the reaction [Doxorubicin results in decreased activity of CAT protein]; Quercetin inhibits the reaction [Doxorubicin results in decreased activity of CAT protein]; sesamin inhibits the reaction [Doxorubicin results in decreased activity of CAT protein]; SIRT6 protein inhibits the reaction [Doxorubicin results in decreased expression of CAT mRNA]; SIRT6 protein inhibits the reaction [Doxorubicin results in decreased expression of CAT protein]; Tannic Acid inhibits the reaction [Doxorubicin results in decreased activity of CAT protein]; thymoquinone inhibits the reaction [Doxorubicin results in decreased activity of CAT protein]; Trimetazidine inhibits the reaction [Doxorubicin results in decreased expression of CAT protein]
IL1A protein promotes the reaction [Doxorubicin results in increased expression of CAT protein]; IL1B protein promotes the reaction [Doxorubicin results in increased expression of CAT protein]; TNF protein promotes the reaction [Doxorubicin results in increased expression of CAT protein]
